Panbela Therapeutics: Funding, Investors & Team (Oct 2026)
Panbela Therapeutics is an innovative biopharmaceutical company that is focused on developing revolutionary treatment options for significant medical challenges. Specifically, the company is currently concentrating on developing therapies for pancreas-related diseases such as pancreatic cancer and pancreatitis. To support its scientific research, Panbela Therapeutics has formed collaborations with esteemed experts in pancreatic disease, including those at Honor Health, Cedars Sinai Medical Center, the University of Minnesota, Mayo Clinic Scottsdale, the Austin Health Cancer Trials Centre, and the Ashford Cancer Centre. Established in 2011, Panbela Therapeutics is headquartered in Minnesota, United States.
Panbela Therapeutics has raised $9.5M across 1 funding round on record, the most recent an undisclosed round of $9.5M announced in Jul 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Panbela Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2023.
Panbela Therapeutics Funding Rounds
Panbela Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Panbela Therapeutics Funding Compared to Other Biotechnology Startups
Panbela Therapeutics' latest round of $9.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Panbela Therapeutics in Biotechnology and Minnesota City
Companies Similar to Panbela Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Panbela Therapeutics Funding FAQs
What does Panbela Therapeutics do?
Panbela Therapeutics is an innovative biopharmaceutical company that is focused on developing revolutionary treatment options for significant medical challenges. Specifically, the company is currently concentrating on developing therapies for pancreas-related diseases such as pancreatic cancer and pancreatitis. To support its scientific research, Panbela Therapeutics has formed collaborations with esteemed experts in pancreatic disease, including those at Honor Health, Cedars Sinai Medical Center, the University of Minnesota, Mayo Clinic Scottsdale, the Austin Health Cancer Trials Centre, and the Ashford Cancer Centre. Established in 2011, Panbela Therapeutics is headquartered in Minnesota, United States.
How much funding has Panbela Therapeutics raised?
Panbela Therapeutics has raised $9.5M across 1 round on record. The most recent is an undisclosed round of $9.5M announced in Jul 2023.
When did Panbela Therapeutics last raise funding?
Panbela Therapeutics' most recent funding round on record is an undisclosed round of $9.5M, announced in Jul 2023.
Who is the CEO of Panbela Therapeutics?
Thomas X Neenan is listed as CEO at Panbela Therapeutics.
Where is Panbela Therapeutics headquartered?
Panbela Therapeutics is based in Minnesota City, Minnesota, United States.
How many employees does Panbela Therapeutics have?
Panbela Therapeutics is in the 1-10 employee band.
How does Panbela Therapeutics' funding compare to other Biotechnology startups?
Panbela Therapeutics' latest round of $9.5M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Panbela Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Panbela Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.